Yang, C.; Wang, Y.; Sims, M.M.; He, Y.; Miller, D.D.; Pfeffer, L.M.
Targeting the Bromodomain of BRG-1/BRM Subunit of the SWI/SNF Complex Increases the Anticancer Activity of Temozolomide in Glioblastoma. Pharmaceuticals 2021, 14, 904.
https://doi.org/10.3390/ph14090904
AMA Style
Yang C, Wang Y, Sims MM, He Y, Miller DD, Pfeffer LM.
Targeting the Bromodomain of BRG-1/BRM Subunit of the SWI/SNF Complex Increases the Anticancer Activity of Temozolomide in Glioblastoma. Pharmaceuticals. 2021; 14(9):904.
https://doi.org/10.3390/ph14090904
Chicago/Turabian Style
Yang, Chuanhe, Yinan Wang, Michelle M. Sims, Yali He, Duane D. Miller, and Lawrence M. Pfeffer.
2021. "Targeting the Bromodomain of BRG-1/BRM Subunit of the SWI/SNF Complex Increases the Anticancer Activity of Temozolomide in Glioblastoma" Pharmaceuticals 14, no. 9: 904.
https://doi.org/10.3390/ph14090904
APA Style
Yang, C., Wang, Y., Sims, M. M., He, Y., Miller, D. D., & Pfeffer, L. M.
(2021). Targeting the Bromodomain of BRG-1/BRM Subunit of the SWI/SNF Complex Increases the Anticancer Activity of Temozolomide in Glioblastoma. Pharmaceuticals, 14(9), 904.
https://doi.org/10.3390/ph14090904